Federal contract award
W81XWH22C0097
PROPOSAL LOG #BA210290 FORMULATION DEVELOPMENT INTRANASAL (IN) DIMETHYL TRISULFIDE (DMTS) AS A CYANIDE MEDICAL COUNTERMEASURE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $151.8K |
| Current contract value | $151.8K |
| Potential contract value / ceiling | $151.8K |
| Start date | Sep 1, 2022 |
| Current end date | Aug 31, 2024 |
| Potential end date | Aug 31, 2024 |
| Latest award activity | Aug 29, 2023 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 29, 2023 | P00002 | $0 | RESEARCH PROJECT WITH THE OBJECTIVE TO DEVELOP AN INTRANASAL FORMULATION OF DIMETHYL TRISULFIDE FOR TREATMENT OF KNOWN OR SUSPECTED CYANIDE POISONING. |
| May 26, 2023 | P00001 | $0 | RESEARCH AND DEVELOPMENT OF NOVEL DMTS FORMULATIONS THAT ARE OPTIMIZED. |
| Aug 17, 2022 | 0 | $151.8K | PROPOSAL LOG #BA210290 FORMULATION DEVELOPMENT INTRANASAL (IN) DIMETHYL TRISULFIDE (DMTS) AS A CYANIDE MEDICAL COUNTERMEASURE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.